Trial Profile
Evaluate the effectiveness and safety of teicoplanin for EIE treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 May 2018
Price :
$35
*
At a glance
- Drugs Teicoplanin (Primary)
- Indications Bacterial endocarditis; Enterococcal infections
- Focus Therapeutic Use
- 03 May 2018 New trial record
- 24 Apr 2018 Results presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases